All News

Drugmaker Group Sets Lobbying Record

Ref: Bloomberg

Tags: NewsPoints Abbott Amgen Bayer Lilly Novo Nordisk Pfizer PhRMA Corporate Affairs

Knight Therapeutics Announces Canadian Regulatory Approval for PROBUPHINE for Opioid Drug Dependence

Ref: GlobeNewswire

Tags: Press Release Knight Therapeutics Braeburn Pharmaceuticals Addictions Health Canada Marketing & Sales Regulatory Affairs Probuphine buprenorphine

Alexion Provides Statement on Superior Court of Justice (STJ) Decision in Brazil Involving Soliris (Eculizumab)

Ref: Business Wire

Tags: Press Release Alexion Brazil Corporate Affairs Soliris

Patients With Resectable NSCLC Achieve Good Pathologic Response With Neoadjuvant Nivolumab

Tags: Conference Dispatch

Bellicum Pharmaceuticals Announces Closing of Public Offering

Ref: GlobeNewswire

Tags: Press Release Bellicum Corporate Affairs

Molecule that dilates blood vessels hints at new way to treat heart disease

Ref: Scripps

Tags: Press Release Stroke Clinical Research (R&D)

Nivolumab Plus Ipilimumab Boosts PFS in Patients With Advanced Lung Cancer, High Mutational Burden

Tags: Conference Dispatch

Vectura Group plc: Directorate Change - Chief Financial Officer

Ref: Vectura Group

Tags: People News Vectura Corporate Affairs

Chief Executive Officer of MOLOGEN AG will not extend Executive Board mandate expiring in October 2018

Ref: Mologen

Tags: People News Mologen Corporate Affairs

Cynata Therapeutics Completes Patent Application to Cover Cymerus Stem Cell Technology in the Treatment of Side Effects Related to CAR-T Therapy

Ref: GlobeNewswire

Tags: Press Release apceth Cynata Therapeutics Corporate Affairs Licensing